Skip to content
← Back to this collection

PUBLICATIONS · 24297868

Early assessment of minimal residual disease identifies patients at very high relapse risk in NPM-ALK-positive anaplastic large-cell lymphoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2014 Jan 16
First author
Damm-Welk C

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Damm-Welk C
      type
      Author
    2. name
      Mussolin L
      type
      Author
    3. name
      Zimmermann M
      type
      Author
    4. name
      Pillon M
      type
      Author
    5. name
      Klapper W
      type
      Author
    6. name
      Oschlies I
      type
      Author
    7. name
      d'Amore ES
      type
      Author
    8. name
      Reiter A
      type
      Author
    9. name
      Woessmann W
      type
      Author
    10. name
      Rosolen A
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Damm-Welk C
      type
      Author
    2. name
      Mussolin L
      type
      Author
    3. name
      Zimmermann M
      type
      Author
    4. name
      Pillon M
      type
      Author
    5. name
      Klapper W
      type
      Author
    6. name
      Oschlies I
      type
      Author
    7. name
      d'Amore ES
      type
      Author
    8. name
      Reiter A
      type
      Author
    9. name
      Woessmann W
      type
      Author
    10. name
      Rosolen A
      type
      Author
    bibliography ids
    1. nci-bib-7501ce7d0ca592524c3c55fc
    book metadata
    content sha256
    6a6f93a2bde6401e1db99d16fb6889d5e69ae0a23280caf5e7bee185f6b667aa
    document type
    citation
    dois
    1. 10.1182/blood-2013-09-526202
    electronic publication date
    display
    2013 Dec 2
    precision
    day
    year
    2013
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:24297868
    immutable id
    pubmed:24297868@6a6f93a2bde6401e1db99d16fb6889d5e69ae0a23280caf5e7bee185f6b667aa
    journal
    abbreviation
    Blood
    issn electronic
    1528-0020
    issn print
    0006-4971
    issue
    3
    name
    Blood
    nlm unique id
    7603509
    pages
    334-7
    volume
    123
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      24297868
      provenance
      batch id
      af10498814d931b53231
      provider
      NCBI PubMed ESummary
      record sha256
      a664ace4aacd268f28cc82375100c90144f278af4fab72cf05c144caf428fe6f
      response sha256
      077a09272afe77e74d5ff01cb33335ddb8a638b7afbafb70ec20e837a0c85c7f
      retrieved at
      2026-09-09T23:47:00.193465+00:00
      publication date
      display
      2014 Jan 16
      precision
      day
      year
      2014
      publication types
      1. Clinical Trial
      2. Journal Article
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/24297868/
      title
      Early assessment of minimal residual disease identifies patients at very high relapse risk in NPM-ALK-positive anaplastic large-cell lymphoma.

      Preserved source evidence · Not medical advice